165 related articles for article (PubMed ID: 36418766)
1. Dexmedetomidine Alters the Inflammatory Profile of Rat Microglia In Vitro.
Scott MC; Haase CM; Olson SD; Cox CS
Neurocrit Care; 2023 Jun; 38(3):688-697. PubMed ID: 36418766
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury.
Gao J; Sun Z; Xiao Z; Du Q; Niu X; Wang G; Chang YW; Sun Y; Sun W; Lin A; Bresnahan JC; Maze M; Beattie MS; Pan JZ
Br J Anaesth; 2019 Dec; 123(6):827-838. PubMed ID: 31623841
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine attenuates lipopolysaccharide-induced proinflammatory response in primary microglia.
Peng M; Wang YL; Wang CY; Chen C
J Surg Res; 2013 Jan; 179(1):e219-25. PubMed ID: 22683080
[TBL] [Abstract][Full Text] [Related]
4. Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia.
Bell MT; Agoston VA; Freeman KA; Puskas F; Herson PS; Mares J; Fullerton DA; Reece TB
J Vasc Surg; 2014 Apr; 59(4):1090-7. PubMed ID: 23850057
[TBL] [Abstract][Full Text] [Related]
5. Cytokine Release by Microglia Exposed to Neurologic Injury Is Amplified by Lipopolysaccharide.
Scott MC; LeBlanc O; Day H; Haase C; Olson SD; Cox CS
J Surg Res; 2024 Apr; 296():142-148. PubMed ID: 38277950
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine inhibits the lipopolysaccharide-stimulated inflammatory response in microglia through the pathway involving TLR4 and NF-κB.
Zhou XY; Liu J; Xu ZP; Fu Q; Wang PQ; Zhang H
Kaohsiung J Med Sci; 2019 Dec; 35(12):750-756. PubMed ID: 31419076
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine inhibits LPS-induced inflammatory responses through peroxisome proliferator-activated receptor gamma (PPARγ) activation following binding to α
Fujimoto M; Higuchi H; Honda-Wakasugi Y; Miyake S; Nishioka Y; Yabuki-Kawase A; Maeda S; Miyawaki T
Eur J Pharmacol; 2021 Feb; 892():173733. PubMed ID: 33220278
[TBL] [Abstract][Full Text] [Related]
8. The role of the vagus nerve on dexmedetomidine promoting survival and lung protection in a sepsis model in rats.
Li Y; Wu B; Hu C; Hu J; Lian Q; Li J; Ma D
Eur J Pharmacol; 2022 Jan; 914():174668. PubMed ID: 34863997
[TBL] [Abstract][Full Text] [Related]
9. The Therapeutic Effect of Dexmedetomidine on Rat Diabetic Neuropathy Pain and the Mechanism.
Lu Y; Lin B; Zhong J
Biol Pharm Bull; 2017 Sep; 40(9):1432-1438. PubMed ID: 28626198
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine alleviates early brain injury following traumatic brain injury by inhibiting autophagy and neuroinflammation through the ROS/Nrf2 signaling pathway.
Feng X; Ma W; Zhu J; Jiao W; Wang Y
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278508
[TBL] [Abstract][Full Text] [Related]
11. The effect of dexmedetomidine on inflammatory inhibition and microglial polarization in BV-2 cells.
Sun Z; Lin Y; Li Y; Ren T; Du G; Wang J; Jin X; Yang LC
Neurol Res; 2018 Oct; 40(10):838-846. PubMed ID: 30071186
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine reduces hippocampal microglia inflammatory response induced by surgical injury through inhibiting NLRP3.
Peng J; Zhang P; Zheng H; Ren YQ; Yan H
Chin J Traumatol; 2019 Jun; 22(3):161-165. PubMed ID: 31056470
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine Attenuates Neuroinflammation In LPS-Stimulated BV2 Microglia Cells Through Upregulation Of miR-340.
Bao Y; Zhu Y; He G; Ni H; Liu C; Ma L; Zhang L; Shi D
Drug Des Devel Ther; 2019; 13():3465-3475. PubMed ID: 31631971
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine Regulates 6-hydroxydopamine-Induced Microglial Polarization.
Zhang P; Li Y; Han X; Xing Q; Zhao L
Neurochem Res; 2017 May; 42(5):1524-1532. PubMed ID: 28247333
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine attenuates lipopolysaccharide-induced renal cell fibrotic phenotypic changes by inhibiting necroinflammation via activating α
Sun Q; Kamath P; Sun Y; Liang M; Wu L; Chang E; Chen Q; Alam A; Liu Y; Zhao H; Ma D
Biomed Pharmacother; 2024 May; 174():116462. PubMed ID: 38513598
[TBL] [Abstract][Full Text] [Related]
16. Tailored Therapeutic Doses of Dexmedetomidine in Evolving Neuroinflammation after Traumatic Brain Injury.
Karakaya D; Cakir-Aktas C; Uzun S; Soylemezoglu F; Mut M
Neurocrit Care; 2022 Jun; 36(3):802-814. PubMed ID: 34782991
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine attenuates hippocampal neuroinflammation in postoperative neurocognitive disorders by inhibiting microRNA-329-3p and activating the CREB1/IL1RA axis.
Chen J; Ding Q; Jiao X; Wang B; Sun Z; Zhang Y; Zhao J
Psychopharmacology (Berl); 2022 Jul; 239(7):2171-2186. PubMed ID: 35412062
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine ameliorates postoperative cognitive dysfunction by inhibiting Toll-like receptor 4 signaling in aged mice.
Zhou XY; Liu J; Xu ZP; Fu Q; Wang PQ; Wang JH; Zhang H
Kaohsiung J Med Sci; 2020 Sep; 36(9):721-731. PubMed ID: 32627922
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine protects against lipopolysaccharide-induced early acute kidney injury by inhibiting the iNOS/NO signaling pathway in rats.
Chen Y; Luan L; Wang C; Song M; Zhao Y; Yao Y; Yang H; Ma B; Fan H
Nitric Oxide; 2019 Apr; 85():1-9. PubMed ID: 30659917
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.
Xiang H; Hu B; Li Z; Li J
Inflammation; 2014 Oct; 37(5):1763-70. PubMed ID: 24803295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
